MAIA Biotechnology
thio trial planned thio | MAIA Biotechnology
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
21 of 35
Similar slides by MAIA Biotechnology
See diffirences between slides (animation)
Investor Presentation
January 2024
thio trial planned | MAIA Biotechnology
Investor Presentation
January 2024
thio trial planned nae thio | MAIA Biotechnology
Investor Presentation
November 2023
thio trial planned a | MAIA Biotechnology
Investor Presentation
November 2023
thio trial planned to expand best combination arms | MAIA Biotechnology
Related slides by other companies
Fusion Pharmaceuticals
Investor Presentation
January 2024
phase trial a first of its kind antibody based targeted alpha therapy study for solid tumors well established cancer found on parent told antibody to or binding | Fusion Pharmaceuticals
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
MindMed
Investor Presentation
November 2024
key highlights of program | MindMed
Erasca
Investor Presentation
August 2023
proposed pivotal phase trial designs creative strategy includes high randomized melanoma trial and tissue agnostic indication | Erasca
Other recent decks by MAIA Biotechnology
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
October 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights